GRFS vs. SNY
GRFS (Grifols, S.A.) and SNY (Sanofi) are both stocks. Both operate in the Drug Manufacturers - General industry within the Healthcare sector. Over the past 10 years, GRFS returned -6.28%/yr vs 5.08%/yr for SNY. At a 0.32 correlation, their price movements are largely independent.
Performance
GRFS vs. SNY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, GRFS achieves a -22.14% return, which is significantly lower than SNY's -9.00% return. Over the past 10 years, GRFS has underperformed SNY with an annualized return of -6.28%, while SNY has yielded a comparatively higher 5.08% annualized return.
GRFS
- 1D
- -1.62%
- 1M
- -8.77%
- YTD
- -22.14%
- 6M
- -19.82%
- 1Y
- -15.59%
- 3Y*
- -6.06%
- 5Y*
- -15.65%
- 10Y*
- -6.28%
SNY
- 1D
- -1.42%
- 1M
- -5.67%
- YTD
- -9.00%
- 6M
- -8.19%
- 1Y
- -7.86%
- 3Y*
- -3.43%
- 5Y*
- -0.10%
- 10Y*
- 5.08%
GRFS vs. SNY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
GRFS Grifols, S.A. | -22.14% | 27.79% | -35.64% | 36.00% | -24.31% | -37.82% | -20.10% | 29.06% | -18.28% | 44.48% |
SNY Sanofi | -9.00% | 4.93% | 1.09% | 6.55% | 0.57% | 7.00% | 0.39% | 20.47% | 6.06% | 9.96% |
Correlation
The correlation between GRFS and SNY is 0.34, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.34 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.24 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.25 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.27 |
Correlation (All Time) Calculated using the full available price history since Jun 2, 2011 | 0.32 |
Fundamentals
GRFS:
$4.95B
SNY:
$100.62B
GRFS:
€0.61
SNY:
€3.09
GRFS:
10.46
SNY:
11.79
GRFS:
0.58
SNY:
1.88
GRFS:
0.79
SNY:
1.20
GRFS:
€7.45B
SNY:
€47.35B
GRFS:
€2.81B
SNY:
€34.18B
GRFS:
€1.56B
SNY:
€12.63B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GRFS vs. SNY — Risk / Return Rank
GRFS
SNY
GRFS vs. SNY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Grifols, S.A. (GRFS) and Sanofi (SNY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GRFS | SNY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.19 | ||
| Sortino ratioReturn per unit of downside risk | -0.26 | ||
| Omega ratioGain probability vs. loss probability | 0.94 | 0.97 | -0.03 |
| Calmar ratioReturn relative to maximum drawdown | -0.49 | -0.47 | -0.01 |
| Martin ratioReturn relative to average drawdown | -0.89 | -0.91 | +0.02 |
Loading charts...
Drawdowns
GRFS vs. SNY - Drawdown Comparison
The maximum GRFS drawdown since its inception was -78.01%, which is greater than SNY's maximum drawdown of -46.46%. Use the drawdown chart below to compare losses from any high point for GRFS and SNY.
Loading charts...
Drawdown Indicators
| GRFS | SNY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -78.01% | -46.46% | -31.55% |
Max Drawdown (1Y)Largest decline over 1 year | -32.22% | -16.70% | -15.52% |
Max Drawdown (3Y)Largest decline over 3 years | -52.68% | -23.37% | -29.31% |
Max Drawdown (5Y)Largest decline over 5 years | -69.29% | -33.52% | -35.77% |
Max Drawdown (10Y)Largest decline over 10 years | -78.01% | -33.52% | -44.49% |
Current DrawdownCurrent decline from peak | -70.24% | -22.50% | -47.74% |
Average DrawdownAverage peak-to-trough decline | -31.83% | -12.20% | -19.63% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 17.58% | 8.69% | +8.89% |
Volatility
GRFS vs. SNY - Volatility Comparison
The current volatility for Grifols, S.A. (GRFS) is 6.88%, while Sanofi (SNY) has a volatility of 8.28%. This indicates that GRFS experiences smaller price fluctuations and is considered to be less risky than SNY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GRFS | SNY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.88% | 8.28% | -1.40% |
Volatility (6M)Calculated over the trailing 6-month period | 24.38% | 16.25% | +8.13% |
Volatility (1Y)Calculated over the trailing 1-year period | 31.82% | 25.71% | +6.11% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 48.78% | 24.89% | +23.89% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 40.32% | 23.48% | +16.84% |
Dividends
GRFS vs. SNY - Dividend Comparison
GRFS's dividend yield for the trailing twelve months is around 2.41%, less than SNY's 5.80% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GRFS Grifols, S.A. | 2.41% | 1.88% | 0.00% | 0.00% | 0.00% | 3.20% | 0.83% | 1.55% | 2.32% | 1.24% | 1.67% | 2.01% |
SNY Sanofi | 5.80% | 4.56% | 4.22% | 3.83% | 4.32% | 3.80% | 3.61% | 3.47% | 4.29% | 3.82% | 4.11% | 3.77% |
Financials
GRFS vs. SNY - Financials Comparison
This section allows you to compare key financial metrics between Grifols, S.A. and Sanofi. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
GRFS vs. SNY - Profitability Comparison
GRFS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Grifols, S.A. reported a gross profit of 630.20M and revenue of 1.73B. Therefore, the gross margin over that period was 36.5%.
SNY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Sanofi reported a gross profit of 8.11B and revenue of 11.24B. Therefore, the gross margin over that period was 72.1%.
GRFS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Grifols, S.A. reported an operating income of 253.09M and revenue of 1.73B, resulting in an operating margin of 14.7%.
SNY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Sanofi reported an operating income of 2.27B and revenue of 11.24B, resulting in an operating margin of 20.2%.
GRFS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Grifols, S.A. reported a net income of 74.20M and revenue of 1.73B, resulting in a net margin of 4.3%.
SNY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Sanofi reported a net income of 1.61B and revenue of 11.24B, resulting in a net margin of 14.4%.
Frequently Asked Questions
GRFS and SNY have a correlation of 0.34, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SNY has higher volatility (8.28%) compared to GRFS (6.88%). In terms of maximum drawdown, GRFS dropped -78.01% vs SNY's -46.46%.
SNY currently has the higher Sharpe Ratio (-0.31 vs -0.49), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for GRFS and SNY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer